Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Placebo
100%
Placebo-controlled
100%
Growth Hormone
100%
Abdominal Fat
100%
Release Factor
100%
Dose-ranging Study
100%
HIV-infected Patients
100%
Visceral Fat
33%
Growth Factors
22%
Insulin-like
22%
Fat Accumulation
22%
Subcutaneous Fat
22%
Central Obesity
22%
Safety Parameters
22%
High-density Lipoprotein Cholesterol (HDL-C)
11%
Lipid Profile
11%
Randomized Placebo-controlled Trial
11%
Metabolic Parameters
11%
Cholesterol
11%
Treatment Strategy
11%
Once-daily
11%
Treatment Group
11%
Glucose Level
11%
Metabolic
11%
Triglycerides
11%
Waist Circumference
11%
Dual-energy X-ray Absorptiometry
11%
Waist-to-hip Ratio
11%
Lipoprotein Ratios
11%
Lean Body Mass
11%
Treatment Safety
11%
Truncal Fat
11%
Limb Fat
11%
Accumulation Parameters
11%
Well Tolerated
11%
Computerized Tomography Scan
11%
Quality of Life Measures
11%
Treatment Durability
11%
Trunk Fat
11%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Lipid Storage
100%
Placebo
100%
Abdominal Fat
100%
Growth Hormone Releasing Factor
100%
Dose-Ranging Study
100%
Tesamorelin
45%
Visceral Fat
27%
Subcutaneous Fat
18%
Somatomedin C
18%
Glucose
18%
Quality of Life
9%
Triacylglycerol
9%
Limb
9%
Computer Assisted Tomography
9%
Dual-Energy X-Ray Absorptiometry
9%
High-Density Lipoprotein
9%
Lean Body Weight
9%
Lipid
9%
Cholesterol
9%
Treatment Group
9%
Trunk
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Placebo
100%
Growth Hormone Releasing Factor
100%
Tesamorelin
45%
Somatomedin C
18%
Glucose
18%
Triacylglycerol
9%
High Density Lipoprotein
9%
Lipid
9%
Cholesterol
9%
Treatment Group
9%